You have requested a machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Neither SPIE nor the owners and publishers of the content make, and they explicitly disclaim, any express or implied representations or warranties of any kind, including, without limitation, representations and warranties as to the functionality of the translation feature or the accuracy or completeness of the translations.
Translations are not retained in our system. Your use of this feature and the translations is subject to all use restrictions contained in the Terms and Conditions of Use of the SPIE website.
15 March 2016Prostate cancer characterization by optical contrast enhanced photoacoustics
Guan Xu, Ming Qin, Ananya Mukundan, Javed Siddiqui, Marilia Takada, Paulo Vilar-Saavedra, Scott A. Tomlins, Raoul Kopelman, Xueding Wang
During the past decades, prostate cancer (PCa), with an annual incident rate much higher than any other cancer, is the most commonly diagnosed cancer in American men. PCa has a relatively low progression rate yet the survival percentage decreases dramatically once the cancer has metastasized. Identifying aggressive from indolent PCa to prevent metastasis and death is critical to improving outcomes for patients with PCa. Standard procedure for assessing the aggressiveness of PCa involves the removal of tumor tissues by transrectal (TR) ultrasound (US) guided needle biopsy. The microscopic architecture of the biopsied tissue is visualized by histological or immunohistochemical staining procedures. The heterogeneity of the microscopic architecture is characterized by a Gleason score, a quantitative description of the aggressiveness of PCa. Due to the inability to identify the cancer cells, most noninvasive imaging modalities can only provide diagnosis of PCa at limited accuracy. This study investigates the feasibility of identifying PCa tumors and characterizing the aggressiveness of PCa by photoacoustic imaging assisted by cancer targeting polyacrylamide (PAA) nanoparticles (NPs). PAA is a biocompatible material used in clinics for the past 20 years. PAA NPs can protect capsulated optical contrast agents from interference by enzymes and enable prolonged systematic circulation in the living biological environment. The cancer targeting mechanism is achieved by conjugating the NPs to F3 peptides, which trace nucleolin overexpressed on the surface of cancer cells. Preliminary studies have shown that the NPs are capable of staining the PCa cells in vivo.
Guan Xu,Ming Qin,Ananya Mukundan,Javed Siddiqui,Marilia Takada,Paulo Vilar-Saavedra,Scott A. Tomlins,Raoul Kopelman, andXueding Wang
"Prostate cancer characterization by optical contrast enhanced photoacoustics", Proc. SPIE 9708, Photons Plus Ultrasound: Imaging and Sensing 2016, 97080I (15 March 2016); https://doi.org/10.1117/12.2213064
The alert did not successfully save. Please try again later.
Guan Xu, Ming Qin, Ananya Mukundan, Javed Siddiqui, Marilia Takada, Paulo Vilar-Saavedra, Scott A. Tomlins, Raoul Kopelman, Xueding Wang, "Prostate cancer characterization by optical contrast enhanced photoacoustics," Proc. SPIE 9708, Photons Plus Ultrasound: Imaging and Sensing 2016, 97080I (15 March 2016); https://doi.org/10.1117/12.2213064